GridAI Technologies Settles $1.03M Loan Default with Cash and Stock
GRDX has more than doubled off its 52-week low of $1.65 on light trading volume (0.4× avg).
Summary
GridAI Technologies Corp. has settled a $1.03 million revolving loan default with a cash payment of $800,000 and the issuance of 71,482 shares of common stock.
Key Events · Financing and Capital Events · GRDX
-
Debt Settlement Agreement
GridAI Technologies Corp. entered into a Debt Settlement and Subscription Agreement on May 14, 2026, with 1396974 BC Ltd. to resolve an outstanding debt of $1,032,315, which included $700,000 in principal and $332,315 in accrued interest from a Revolving Loan Agreement.
-
Settlement Terms
The company will satisfy its obligation through a cash payment of $800,000 (comprising $700,000 principal and $100,000 interest) and the issuance of 71,482 shares of common stock at a deemed price of $3.25 per share to cover the remaining $232,315 in accrued interest.
-
Resolution of Default
This agreement resolves a previously disclosed default on the Revolving Loan Agreement, which was highlighted in the company's recent 10-K filing that also raised substantial doubt about its ability to continue as a going concern.
-
Financial Stability Impact
The settlement of this significant debt improves the company's financial position and reduces immediate liquidity pressures, following recent efforts to raise $7.79 million through private placements and regain Nasdaq compliance.
Analysis · GRDX · Life Sciences
This filing is highly important as GridAI Technologies Corp. has resolved a significant loan default, a critical step for a company that recently disclosed substantial doubt about its ability to continue as a going concern. The settlement of over $1 million in debt, through a combination of cash and stock, addresses a key financial vulnerability and removes an immediate threat of further action from the lender. This action improves the company's financial stability and provides a clearer path forward, following recent efforts to regain Nasdaq compliance and raise additional capital.
At the time of this filing, GRDX was trading at $3.84 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $23.8M. The 52-week trading range was $1.65 to $7.02. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.